Your Partner for Growth, Hybridan

Hybridan

Your Partner for Growth

Our passion is raising growth capital for exciting, fast growth companies that want to take their business to the next level. We raise capital for companies both listed and unlisted in the most efficient manner possible and pride ourselves as being one of the few consistently profitable broking firms in the City. This has been achieved through a highly disciplined approach when seeking to create both corporate and institutional relationships.

Equity Bottom-Up

<ul>
<li>8th September: Project Glow Topco Limited, the ultimate holding Company of The Beauty Tech Group Limited, a global leader in the rapidly growing at-home beauty technology market, encompasses three distinct, innovative and premium beauty technology brands - CurrentBody Skin, ZIIP Beauty and Tria Laser - under which it develops, manufactures and retails at-home beauty devices.</li>
<li>In FY24, the Group reported revenue of £101.1m and adjusted EBITDA of £22.9m.</li>
<li>Between the financial period for the 16 months ended 31 January 2023 (FY22) and FY24, the Group's own-brand revenue and adjusted EBITDA grew at a compound annual growth rate of 73.6% and 92.9% respectively. </li>
</ul>


8th September: Project Glow Topco Limited, the ultimate holding Company of The Beauty Tech Group Limited, a global leader in the rapidly growing at-home beauty technology market, encompasses three distinct, innovative and premium beauty technology brands - CurrentBody Skin, ZIIP Beauty and Tria Laser - under which it develops, manufactures and retails at-home beauty devices.
In FY24, the Group reported revenue of £101.1m and adjusted EBITDA of £22.9m.
Between the financial period for the 16 months ended 31 January 2023 (FY22) and FY24, the Group's own-brand revenue and adjusted EBITDA grew at a compound annual growth rate of 73.6% and 92.9% respectively. 


<ul>
<li>Cobra Resources 2.60p £20.63m (COBR.L) The mineral exploration and development Company advancing a Rare Earth Element (REE) discovery at its Boland Project in South Australia announced initial results from re-analysis of historical, uraniumfocused rotary mud drilling from a recently acquired tenement (EL 6742) that covers over 750km square of the prospective Yaninee Palaeochannel system.</li>
<li>Results indicate the presence of a REE system with characteristics reflective of Boland on the Narlaby Palaeochannel 10-20km to the northeast.</li>
<li>This significantly increases the scale of the ionic REE system within the Pidinga Formation amenable to lowcost, low disturbance In Situ Recovery. </li>
</ul>


Cobra Resources 2.60p £20.63m (COBR.L) The mineral exploration and development Company advancing a Rare Earth Element (REE) discovery at its Boland Project in South Australia announced initial results from re-analysis of historical, uraniumfocused rotary mud drilling from a recently acquired tenement (EL 6742) that covers over 750km square of the prospective Yaninee Palaeochannel system.
Results indicate the presence of a REE system with characteristics reflective of Boland on the Narlaby Palaeochannel 10-20km to the northeast.
This significantly increases the scale of the ionic REE system within the Pidinga Formation amenable to lowcost, low disturbance In Situ Recovery. 


<ul>
<li>The UK-based biopharmaceutical Company developing regulatory approved, cannabinoid medicines to treat complex, chronic conditions, announced that trading in the Company's ordinary shares on the OTCQB Venture Market in the US will commence today.</li>
<li>There is no associated capital raise with this cross trade and the Ordinary Shares will continue to trade on the Company's primary listing market, the Apex segment of the Aquis Stock Exchange.</li>
<li>Cross trading on OTCQB allows the Company to access one of the world's largest investment markets to expand its reach into a broader pool of investors and build brand awareness in the most important pharmaceutical market in the world.</li>
</ul>


The UK-based biopharmaceutical Company developing regulatory approved, cannabinoid medicines to treat complex, chronic conditions, announced that trading in the Company's ordinary shares on the OTCQB Venture Market in the US will commence today.
There is no associated capital raise with this cross trade and the Ordinary Shares will continue to trade on the Company's primary listing market, the Apex segment of the Aquis Stock Exchange.
Cross trading on OTCQB allows the Company to access one of the world's largest investment markets to expand its reach into a broader pool of investors and build brand awareness in the most important pharmaceutical market in the world.


United Kingdom

Directa Plus plc Limited manufactures and sells graphene products for industrial and commercial applications. The company was incorporated in 2003 and is based in the United Kingdom.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Directa Plus (DCTA LN)

Hybridan Small Cap Feast: 24/09/2025

8th September: Project Glow Topco Limited, the ultimate holding Company of The Beauty Tech Group Limited, a global leader in the rapidly growing at...

Hybridan

Hybridan Small Cap Feast: 04/08/2025

Initial results define two large higher-grade zones exceeding 80km2 that flank the main incised channel, reflecting similar depositional geology to...

Hybridan

Hybridan Small Cap Feast: 14/04/2025

Cross trading on OTCQB allows the Company to access one of the world's largest investment markets to expand its reach into a broader pool of...

Hybridan

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)